Moderna, Inc. (MRNA)
Moderna Market Cap : 83.55B for Nov. 17, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 83.55B |
| November 16, 2026 | 86.97B |
| November 13, 2026 | 90.24B |
| November 12, 2026 | 93.47B |
| November 11, 2026 | 100.47B |
| November 10, 2026 | 101.34B |
| November 09, 2026 | 108.68B |
| November 06, 2026 | 102.69B |
| November 05, 2026 | 97.55B |
| November 04, 2026 | 104.39B |
| November 03, 2026 | 92.29B |
| November 02, 2026 | 88.11B |
| October 30, 2026 | 88.47B |
| October 29, 2026 | 88.88B |
| October 28, 2026 | 85.45B |
| October 27, 2026 | 82.98B |
| October 26, 2026 | 79.34B |
| October 23, 2026 | 79.84B |
| October 22, 2026 | 80.85B |
| October 21, 2026 | 98.08B |
| October 20, 2026 | 96.59B |
| October 19, 2026 | 90.53B |
| October 16, 2026 | 86.99B |
| October 15, 2026 | 94.36B |
| October 14, 2026 | 90.29B |
| Date | Value |
|---|---|
| October 13, 2026 | 86.28B |
| October 12, 2026 | 85.28B |
| October 09, 2026 | 89.78B |
| October 08, 2026 | 78.60B |
| October 07, 2026 | 78.40B |
| October 06, 2026 | 74.80B |
| October 05, 2026 | 81.08B |
| October 02, 2026 | 75.81B |
| October 01, 2026 | 75.39B |
| September 30, 2026 | 76.84B |
| September 29, 2026 | 81.18B |
| September 28, 2026 | 78.71B |
| September 25, 2026 | 79.35B |
| September 24, 2026 | 77.73B |
| September 23, 2026 | 72.66B |
| September 22, 2026 | 72.84B |
| September 21, 2026 | 69.00B |
| September 18, 2026 | 61.46B |
| September 17, 2026 | 63.07B |
| September 16, 2026 | 58.10B |
| September 15, 2026 | 57.36B |
| September 14, 2026 | 58.53B |
| September 11, 2026 | 57.44B |
| September 10, 2026 | 54.51B |
| September 09, 2026 | 54.11B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Revolution Medicines, Inc. | 35.18B |
| Vaxcyte, Inc. | 8.868B |
| Twist Bioscience Corp. | 7.019B |
| BioNTech SE | 21.04B |
| Vir Biotechnology, Inc. | 1.567B |
Market Cap Related Metrics
| PS Ratio | 33.07 |
| Price to Book Value | 12.22 |
| Price | 206.80 |
| Earnings Yield | -3.43% |